| Literature DB >> 25624844 |
Jerzy Liszka1, Maciej Haberka2, Zbigniew Tabor3, Maciej Finik1, Zbigniew Gąsior2.
Abstract
INTRODUCTION: Left ventricular remodeling (LVR) is the most prognostically important consequence of acute myocardial infarction (AMI). The aim of the study was to assess the value of speckle tracking echocardiography in the prediction of left ventricular remodeling in patients after AMI and primary coronary angioplasty (PCI).Entities:
Keywords: acute coronary syndrome; coronary artery disease; echocardiography
Year: 2014 PMID: 25624844 PMCID: PMC4296067 DOI: 10.5114/aoms.2014.47821
Source DB: PubMed Journal: Arch Med Sci ISSN: 1734-1922 Impact factor: 3.318
Infarct-related artery (IRA) in group I and coronary artery requiring PCI in group II with the number of patients
| LAD | RCA | Cx | OM | D1 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| M | F | M | F | M | F | M | F | M | F | |
| 15 | 5 | 21 | 7 | 8 | 3 | 2 | 1 | 1 | 0 | |
|
| 1.0 | 1.0 | 1.0 | 1.0 | – | |||||
| 5 | 8 | 2 | 6 | 2 | 1 | 1 | 0 | 1 | 1 | |
|
| 1.0 | 0.40 | 0.54 | – | – | |||||
|
| 0.16 | 0.24 | 0.54 | 1.0 | 1.0 | |||||
LAD – left anterior descending, RCA – right coronary artery, Cx – circumflex, OM – obtuse marginal, D1 – diagonal, M – males, F – females.
Routine and speckle tracking echocardiography (STE) in group I and II patients at baseline and 90 days after PCI
| Parameter | Baseline visit | Control visit 90 days after PCI | ||||
|---|---|---|---|---|---|---|
| Group I | Group II | Value of | Group I | Group II | Value of | |
| LVEDV [ml] | 98.37 ±26.7 | 85.36 ±23.8 | < 0.05 | 107.57 ±36.9 | 87.36 ±22.7 | 0.02 |
| LVESV [ml] | 41.56 ±18.5 | 33.20 ±16.0 | 0.05 | 44.83 ±22.16 | 32.44 ±16.9 | 0.02 |
| EF (%) | 56.98 ±8.9 | 62.88 ±7.5 | < 0.01 | 58.32 ±8.9 | 64.16 ±6.4 | < 0.01 |
| WMSI | 1.16 ±0.2 | 1.02 ±0.1 | < 0.01 | 1.2 ±0.3 | 1.02 ±0.1 | < 0.01 |
| sCapex (%) | –22.77 ±10.5 | –26.81 ±10.22 | 0.10 | –22.85 ±9.9 | –29.03 ±8.6 | < 0.01 |
| sCbas (%) | –16.91 ±7.2 | –20.46 ±6.7 | 0.04 | –18.50 ±6.4 | –20.88 ±6.3 | 0.12 |
| sRapex (%) | 11.89 ±7.0 | 13.79 ±7.8 | 0.27 | 14.15 ±5.5 | 13.02 ±6.6 | 0.09 |
| sRbas (%) | 19.00 ±10.3 | 20.85 ±6.9 | 0.40 | 19.86 ±8.1 | 24.16 ±9.7 | 0.04 |
| sLa2 (%) | –11.01 ±3.7 | –12.73 ±2.1 | 0.03 | –11.80 ±4.2 | –12.21 ±2.9 | 0.66 |
| sLa4 (%) | –11.36 ±4.3 | –12.63 ±2.9 | 0.18 | 12.18 ±4.9 | –14.23 ±3.6 | 0.06 |
| sTa2 (%) | 14.02 ±7.5 | 14.03 ±6.5 | 0.99 | 14.28 ±8.2 | 17.87 ±9.1 | 0.08 |
| sTa4 (%) | 14.18 ±8.3 | 14.79 ±7.7 | 0.75 | 15.00 ±8.6 | 15.69 ±7.5 | 0.72 |
| Rot apex [o] | 6.43 ±3.7 | 5.52 ±3.8 | 0.31 | 5.17 ±3.1 | 7.38 ±3.9 | 0.01 |
| Rot bas [o] | –2.83 ±2.1 | –3.78 ±2.6 | 0.08 | –3.58 ±2.6 | –5.22 ±3.5 | 0.02 |
| Torsion [o] | 8.74 ±5.0 | 9.38 ±5.5 | 0.73 | 8.22 ±4.3 | 12.24 ±6.1 | < 0.01 |
PCI – percutaneous coronary intervention, LVEDV – left ventricular end diastolic volume, LVESV – left ventricular end systolic volume, EF – ejection fraction, WMSI – wall motion score index, s – strain, C – circumferential, R – radial, L – longitudinal, T – transverse, apex – apical segments, bas – basal segments, a2 – apical 2-chamber view, a4 – apical 4-chamber view, Rot – rotation.
Group I: patients with and without left ventricle remodeling R (+) vs. R (–)
| Parameter | Group I R (+) | Group I R (–) | Value of |
|---|---|---|---|
| Baseline characteristics: | |||
| Age | 61.48 ±12.1 | 64.65 ±11.2 | 0.35 |
| Females/males | 2 (3%)/15 (24%) | 14 (22%)/32 (51%) | 0.19 |
| Smoking | 8 (47%) | 23 (50%) | 0.12 |
| Diabetes | 5 (29%) | 9 (19%) | 0.49 |
| Arterial hypertension | 11 (65%) | 31 (67%) | 0.84 |
| Pharmacotherapy: | |||
| Acetylsalicylic acid | 17 (100%) | 46 (100%) | 1.0 |
| Clopidogrel | 17 (100%) | 46 (100%) | 1.0 |
| β-Blockers | 17 (100%) | 46 (100%) | 1.0 |
| ACE-I/ARB | 16 (94%) | 42 (91%) | 0.72 |
| Statins | 17 (100%) | 46 (100%) | 1.0 |
| Infarct-related artery: | |||
| Left anterior descending | 4 | 17 | 0.37 |
| Right coronary artery | 8 | 20 | 1.0 |
| Circumflex artery | 5 | 9 | 0.49 |
| Coronary artery disease: | |||
| 1-vessel CAD | 3 (18%) | 18 (39%) | 0.14 |
| 2-vessel CAD | 8 (47%) | 13 (28%) | 0.23 |
| 3-vessel CAD | 6 (35%) | 15 (33%) | 1.0 |
| STEMI anterior | 3 | 8 | 1.0 |
| STEMI inferior | 7 | 20 | 1.0 |
| STEMI lateral | 1 | 1 | 0.47 |
| NSTEMI | 6 | 17 | 1.0 |
| Killip class | 1.17 ±0.4 | 1.41 ±0.4 | 0.31 |
| Time to reperfusion | 15 ±21.5 | 8 ±12.6 | 0.03 |
| TIMI 3 | 17 (100%) | 46 (100%) | 1.0 |
| Stent implantation | 17 (100%) | 46 (100%) | 1.0 |
CAD – coronary artery disease, ACE-I – angiotensin-converting enzyme inhibitors, ARB – angiotensin receptor blockers, STEMI – ST elevation myocardial infarction, TIMI – thrombolysis in myocardial infarction
Speckle tracking echocardiography (STE) in group I R (–) and group I R (+) patients at baseline and 90 days after PCI
| Parameter | Baseline visit | Control visit 90 days after PCI | ||||
|---|---|---|---|---|---|---|
| Group R (–) | Group R (+) | Value of | Group R (–) | Group R (+) | Value of | |
| LVEDV [ml] | 95.50 ±26.8 | 106.12 ±32.9 | 0.19 | 94.85 ±25.8 | 142.00 ±41.06 | < 0.01 |
| LVESV [ml] | 38.46 ±13.7 | 49.94 ±26.4 | < 0.03 | 36.43 ±13.5 | 67.53 ±25.3 | < 0.01 |
| EF (%) | 58.50 ±8.6 | 52.88 ±8.4 | < 0.02 | 61.20 ±7.7 | 50.53 ±7.0 | < 0.01 |
| WMSI | 1.14 ±0.2 | 1.18 ±0.2 | 0.41 | 1.09 ±0.1 | 1.32 ±0.3 | < 0.05 |
| MR grade | 1.89 ±1.7 | 2.02 ±2.2 | 0.89 | 1.72 ±1.8 | 3.19 ±2.3 | < 0.01 |
| sCapex (%) | –23.11 ±10.6 | –21.83 ±10.3 | 0.67 | –25.53 ±8.85 | –15.58 ±8.9 | < 0.01 |
| sCbas (%) | –17.85 ±7.4 | –14.36 ±5.1 | 0.09 | –19.78 ±6.3 | –15.02 ±5.6 | < 0.01 |
| sRapex (%) | 11.72 ±6.8 | 12.34 ±7.8 | 0.76 | 14.15 ±5.5 | 9.96 ±8.4 | < 0.03 |
| sRbas (%) | 20.15 ±10.6 | 15.92 ±9.2 | 0.15 | 20.83 ±8.3 | 17.23 ±7.1 | 0.12 |
| sLa2 (%) | –11.61 ±3.6 | –9.40 ±3.7 | < 0.04 | –12.2 ±4.0 | –10.64 ±4.5 | 0.18 |
| sLa4 (%) | –11.99 ±4.2 | –9.65 ±4.3 | 0.06 | –13.47 ±3.9 | –8.71 ±5.8 | < 0.01 |
| sTa2 (%) | 14.81 ±6.9 | 11.88 ±8.7 | 0.17 | 14.37 ±7.9 | 14.03 ±9.3 | 0.89 |
| sTa4 (%) | 15.58 ±8.0 | 10.36 ±8.2 | < 0.03 | 16.67 ±8.3 | 10.48 ±8.1 | < 0.03 |
| Rot apex [o] | 6.92 ±3.9 | 5.08 ±2.6 | 0.08 | 5.66 ±3.2 | 3.84 ±2.5 | < 0.04 |
| Rot bas [o] | –2.79 ±1.9 | –2.93 ±2.7 | 0.8 | –3.71 ±2.8 | –3.21 ±1.9 | 0.5 |
| Torsion [o] | 9.09 ±5.4 | 7.79 ±5.3 | 0.3 | 8.98 ±4.6 | 6.15 ±4.1 | < 0.03 |
LVEDV – left ventricular end diastolic volume, LVESV – left ventricular end systolic volume, EF – ejection fraction, WMSI – wall motion score index, MR – mitral regurgitation, s – strain, C – circumferential, R – radial, L – longitudinal, T – transverse, apex – apical segments, bas – basal segments, a2 – apical 2-chamber view, a4 – apical 4-chamber view, Rot – rotation.
Speckle tracking echocardiography (STE) in group I R (–) and group I R (+) patients at baseline and 30 days after PCI
| Parameter | Baseline visit | Control visit 30 days after PCI | ||||
|---|---|---|---|---|---|---|
| Group R (–) | Group R (+) | Value of | Group R (+) | Group R (–) | Value of | |
| sCapex (%) | –23.11 ±10.6 | –21.83 ±10.3 | 0.67 | –25.53 ±8.85 | –15.58 ±8.9 | < 0.01 |
| sCbas (%) | –17.85 ±7.4 | –14.36 ±5.1 | 0.09 | –19.78 ±6.3 | –15.02 ±5.6 | < 0.01 |
| sRapex (%) | 11.72 ±6.8 | 12.34 ±7.8 | 0.76 | 14.15 ±5.5 | 9.96 ±8.4 | < 0.03 |
| sRbas (%) | 20.15 ±10.6 | 15.92 ±9.2 | 0.15 | 20.83 ±8.3 | 17.23 ±7.1 | 0.12 |
| sLa2 (%) | –11.61 ±3.6 | –9.40 ±3.5 | < 0.04 | –12.2 ±4.0 | –10.64 ±4.5 | 0.18 |
| sLa4 (%) | –11.99 ±4.2 | –9.65 ±4.3 | 0.06 | –13.47 ±3.9 | –8.71 ±5.8 | < 0.01 |
| sTa2 (%) | 14.81 ±6.9 | 11.88 ±8.7 | 0.17 | 14.37 ±7.9 | 14.03 ±9.3 | 0.89 |
| sTa4 (%) | 15.58 ±8.0 | 10.36 ±8.2 | < 0.03 | 16.67 ±8.3 | 10.48 ±8.1 | < 0.03 |
| Rot apex [o] | 6.92 ±3.9 | 5.08 ±2.6 | 0.08 | 5.66 ±3.2 | 3.84 ±2.5 | < 0.04 |
| Rot bas [o] | –2.79 ±1.9 | –2.93 ±2.7 | 0.8 | –3.71 ±2.8 | –3.21 ±1.9 | 0.50 |
| Torsion [o] | 9.09 ±5.4 | 7.79 ±5.3 | 0.3 | 8.98 ±4.6 | 6.15 ±4.1 | < 0.03 |
s – strain, C – circumferential, R – radial, L – longitudinal, T – transverse, apex – apical segments, bas – basal segments, a2 – apical 2-chamber view, a4 – apical 4-chamber view, Rot – rotation.
Univariate and multivariate logistic regression analysis: baseline echocardiographic parameters and left ventricle remodeling
| Parameter | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | Value of | OR | 95% CI | Value of | |
| LVESV | 0.97 | 0.94; 0.99 | 0.01 | |||
| EF | 1.09 | 1.02; 1.16 | < 0.01 | 0.89 | 0.8; 0.98 | < 0.01 |
| sCbas | 1.10 | 1.01; 1.20 | 0.03 | |||
| sLa2 | 0.79 | 0.66; 0.94 | < 0.01 | |||
| sLa4 | 1.18 | 1.02; 1.37 | 0.02 | |||
| sTa4 | 1.09 | 1.00; 1.18 | 0.03 | |||
| sCapex 30 | 1.17 | 1.07; 1.27 | < 0.01 | 0.88 | 0.79; 0.97 | < 0.01 |
| sCbas 30 | 1.15 | 1.04; 1.28 | < 0.01 | |||
| sRapex 30 | 1.13 | 1.02; 1.24 | 0.01 | |||
| sRbas 30 | 1.08 | 1.00; 1.16 | 0.04 | |||
| sLa4 30 | 1.29 | 1.10; 1.50 | < 0.01 | 0.82 | 0.68; 0.96 | 0.01 |
| sTa4 30 | 1.10 | 1.02; 1.20 | 0.01 | |||
| Rot apex 30 | 1.32 | 1.06; 1.66 | 0.01 | |||
| Torsion 30 | 0.84 | 0.73; 0.95 | < 0.01 | |||
| WMSI | 0.10 | 0.007; 1.54 | 0.09 | |||
OR – odds ratio, CI – confidence interval, LVESV – left ventricular end systolic volume, EF – ejection fraction, s – strain, C – circumferential, R – radial, L – longitudinal, T – transverse, apex – apical segments, bas – basal segments, a2 – apical 2-chamber view, a4 – apical 4-chamber view, Rot – rotation.
Echocardiographic parameters obtained at the baseline visit predicting left ventricle remodeling in the 3-month follow-up
| Parameter | Value | Sensitivity | Specificity | ACC | PPV | NPV |
|---|---|---|---|---|---|---|
| sLa4 0 | –9.98 | 0.803 | 0.647 | 0.773 | 0.905 | 0.440 |
| sLa2 0 | –7.98 | 0.94 | 0.35 | 0.83 | 0.86 | 0.60 |
| sTa4 0 | 4.03 | 0.97 | 0.35 | 0.85 | 0.86 | 0.75 |
| sCapex 30 | –15.92 | 0.930 | 0.588 | 0.864 | 0.904 | 0.667 |
| sLa4 30 | –7.86 | 0.944 | 0.529 | 0.864 | 0.893 | 0.692 |
sLa4 0 – baseline longitudinal 4-chamber strain, sCapex 30 – apical segments circumferential strain 30 days after AMI, sLa4 30 – longitudinal 4-chamber strain 30 days after AMI, ACC – accuracy, PPV – positive predictive value, NPV – negative predictive value.